SenzaGen AB
SenzaGen Group is a leading company in in vitro science and testing, specializing in non-animal test methods to replace traditional animal testing. Their proprietary GARD® assays use genomics and machine learning to accurately assess skin and respiratory sensitization, providing high-performance, regulatory-compliant testing services. The company supports chemical, cosmetic, medical device, and pharmaceutical industries by offering safety and efficacy assessments, regulatory advisory, and innovation services. SenzaGen operates GLP-certified laboratories and has expanded its portfolio through acquisitions, including VitroScreen and ToxHub, enhancing capabilities in 3D tissue models and toxicological consulting. The company is listed on Nasdaq Stockholm and collaborates with global CROs and distributors, serving industry leaders such as Cargill, Corteva Agriscience, ExxonMobil, L’Oréal, and Sonova.
SenzaGen AB
SenzaGen Group is a leading company in in vitro science and testing, specializing in non-animal test methods to replace traditional animal testing. Their proprietary GARD® assays use genomics and machine learning to accurately assess skin and respiratory sensitization, providing high-performance, regulatory-compliant testing services. The company supports chemical, cosmetic, medical device, and pharmaceutical industries by offering safety and efficacy assessments, regulatory advisory, and innovation services. SenzaGen operates GLP-certified laboratories and has expanded its portfolio through acquisitions, including VitroScreen and ToxHub, enhancing capabilities in 3D tissue models and toxicological consulting. The company is listed on Nasdaq Stockholm and collaborates with global CROs and distributors, serving industry leaders such as Cargill, Corteva Agriscience, ExxonMobil, L’Oréal, and Sonova.